Drug intelligence / Profile preview

AZD7986 + itraconazole

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Oral
01

Overview

AZD7986 + itraconazole refers to the combination of AZD7986, a small molecule inhibitor of dipeptidyl peptidase 1 (DPP1), and itraconazole, a triazole antifungal agent. AZD7986 blocks DPP1, an enzyme essential for activation of neutrophil serine proteases such as neutrophil elastase, aiming for disease modification in neutrophil-driven inflammatory conditions like COPD and related lung diseases. Itraconazole inhibits fungal cytochrome P450-dependent 14α-demethylase, preventing ergosterol synthesis and fungal cell membrane formation. The combination was primarily studied to assess pharmacokinetic interactions; itraconazole is a strong CYP3A4 inhibitor and may impact the metabolism and exposure of AZD7986.

Brand names
Sporanox
Other names
dipeptidyl peptidase 1 inhibitor + itraconazoleAZD7986 + SporanoxAZD7986 + itraconazole oral solution
02

Targets

CYP3A4 (Cytochrome P450 3A4)CTSC (DPP1)CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on AZD7986 + itraconazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AZD7986 + itraconazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call